🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Exclusive: AmerisourceBergen eyes Walgreens' drug distribution business - sources

Published 05/04/2020, 05:21 PM
Updated 05/04/2020, 05:25 PM
© Reuters.
COR
-
WBA
-

(Reuters) - AmerisourceBergen Corp (N:ABC), one of the largest U.S. drug distributors, has approached Walgreens Boots Alliance Inc (O:WBA) to explore a deal for its pharmaceutical wholesaling division, people familiar with the matter said on Monday.

AmerisourceBergen is willing to pay about $6 billion for the Walgreens business, which operates mainly under the Alliance Healthcare brand, one of the sources said. T

There is no certainty that the two companies will negotiate a deal, the sources added, asking not to be identified because the matter is confidential. Walgreens and AmerisourceBergen did not immediately respond to requests for comment.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.